These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
458 related items for PubMed ID: 7994909
1. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CG. Clin Exp Immunol; 1994 Dec; 98(3):448-53. PubMed ID: 7994909 [Abstract] [Full Text] [Related]
2. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Csernok E, Ahlquist D, Ullrich S, Gross WL. Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006 [Abstract] [Full Text] [Related]
3. In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG). van der Geld YM, Huitema MG, Franssen CF, van der Zee R, Limburg PC, Kallenberg CG. Clin Exp Immunol; 2000 Dec; 122(3):504-13. PubMed ID: 11122262 [Abstract] [Full Text] [Related]
4. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis. Muller Kobold AC, Kallenberg CG, Tervaert JW. Br J Rheumatol; 1998 Aug; 37(8):901-7. PubMed ID: 9734683 [Abstract] [Full Text] [Related]
5. Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Chen M, Yu F, Zhang Y, Zou WZ, Zhao MH, Wang HY. Kidney Int; 2005 Nov; 68(5):2225-9. PubMed ID: 16221222 [Abstract] [Full Text] [Related]
6. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Geffriaud-Ricouard C, Noël LH, Chauveau D, Houhou S, Grünfeld JP, Lesavre P. Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736 [Abstract] [Full Text] [Related]
7. T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis. Griffith ME, Coulthart A, Pusey CD. Clin Exp Immunol; 1996 Feb; 103(2):253-8. PubMed ID: 8565308 [Abstract] [Full Text] [Related]
8. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients. Harper L, Radford D, Plant T, Drayson M, Adu D, Savage CO. Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931 [Abstract] [Full Text] [Related]
9. Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Schönermarck U, Lamprecht P, Csernok E, Gross WL. Rheumatology (Oxford); 2001 Feb; 40(2):178-84. PubMed ID: 11257154 [Abstract] [Full Text] [Related]
10. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Daouk GH, Palsson R, Arnaout MA. Kidney Int; 1995 Jun; 47(6):1528-36. PubMed ID: 7643521 [Abstract] [Full Text] [Related]
11. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis. Dolman KM, Stegeman CA, van de Wiel BA, Hack CE, von dem Borne AE, Kallenberg CG, Goldschmeding R. Clin Exp Immunol; 1993 Sep; 93(3):405-10. PubMed ID: 8370167 [Abstract] [Full Text] [Related]
12. In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis. Muller Kobold AC, van Wijk RT, Franssen CF, Molema G, Kallenberg CG, Tervaert JW. Clin Exp Rheumatol; 1999 Sep; 17(4):433-40. PubMed ID: 10464553 [Abstract] [Full Text] [Related]
13. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides. Van Der Geld YM, Simpelaar A, Van Der Zee R, Tervaert JW, Stegeman CA, Limburg PC, Kallenberg CG. Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067 [Abstract] [Full Text] [Related]
14. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis. van der Geld YM, Tool AT, Videler J, de Haas M, Tervaert JW, Stegeman CA, Limburg PC, Kallenberg CG, Roos D. Clin Exp Immunol; 2002 Sep; 129(3):562-70. PubMed ID: 12197900 [Abstract] [Full Text] [Related]
15. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis. Fienberg R, Mark EJ, Goodman M, McCluskey RT, Niles JL. Hum Pathol; 1993 Feb; 24(2):160-8. PubMed ID: 8381764 [Abstract] [Full Text] [Related]
16. Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase. Zhang X, Dong Y, Zeng X, Li Y, Tang F. Chin Med Sci J; 2002 Mar; 17(1):32-5. PubMed ID: 12894882 [Abstract] [Full Text] [Related]
17. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity. van de Wiel BA, Dolman KM, van der Meer-Gerritsen CH, Hack CE, von dem Borne AE, Goldschmeding R. Clin Exp Immunol; 1992 Dec; 90(3):409-14. PubMed ID: 1458677 [Abstract] [Full Text] [Related]
18. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC, European Vasculitis Study Group (EUVAS). Kidney Int; 2002 Jan; 61(1):80-9. PubMed ID: 11786087 [Abstract] [Full Text] [Related]
20. In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase. Popa ER, Franssen CF, Limburg PC, Huitema MG, Kallenberg CG, Tervaert JW. Arthritis Rheum; 2002 Jul; 46(7):1894-904. PubMed ID: 12124874 [Abstract] [Full Text] [Related] Page: [Next] [New Search]